Revised outcome of the board meeting held on 08/10/2025 in respect of the authorisation of Daksha Agarwal.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company filed a revised outcome of its board meeting held on October 8, 2025, correcting a clerical typo where the date was wrongly mentioned as October 10, 2025. The actual resolution approved the authorization of Company Secretary Daksha Agarwal to represent the company before regulators like BSE, SEBI, and ROC. The authorization is specifically tied to the issue and allotment of 1,52,82,000 (about 1.53 crore) convertible equity warrants. The meeting was short, running only from 2:00 PM to 2:15 PM. The filing was signed by Unni Krishnan Nair, Manager and Whole-time Key Managerial Personnel.
For retail investors, this is essentially a procedural correction combined with a routine authorization for a convertible warrant issue. The key takeaway is the company's plan to issue 1.53 crore convertible warrants, which could dilute existing shareholders if and when converted. No immediate change in board composition or leadership.